Sursa foto: smartradio.ro
More than 120,000 Moderna vaccine doses have arrived in the country, the National Committee for the Coordination of Activities on Vaccination against COVID-19 (CNCAV) informed on Thursday, agerpres reports.
The transport is provided by the producing company, and the vaccine doses will be brought to Bucharest by land.
According to CNCAV, the 128,400 doses of Moderna vaccine will arrive on Thursday at the Cantacuzino National Institute for Medical-Military Research and Development, after which 42,000 will be distributed to the Constanta Regional Storage Center and 86,400 to the Timisoara Regional Storage Center.
Until now, 853,200 Moderna doses have been received and 542,078 have already been used to immunize the population.
Sursa foto: smartradio.ro
A number of 100,800 vaccine doses produced by AstraZeneca have left on Friday morning the Cantacuzino National Institute for Medical-Military Research and Development venue, with the destination the Republic of Moldova. In order to support the Republic of Moldova authorities involved in the fight for combating the COVID-19 pandemic, the Romanian Government has decided to continue granting humanitarian aid, with a new batch of vaccines against COVID-19, reads the Facebook page of Rovaccinare platform.
The mission is carried out with the General Inspectorate for Emergency Situations (IGSU) s transport means, on the Bucharest - Chisinau route and back.
Sursa foto: smartradio.ro
The largest amount of vaccine from AstraZeneca, which consists of 643,200 doses, will arrive on Tuesday, 4 May, at the Cantacuzino National Institute for Medical-Military Research and Development, on Monday informed the Communication Group of the National Committee for the Coordination of Vaccination Activities against COVIV-19 (CNCAV).
The transport is ensured by the manufacturing company, and the doses of the vaccine will be brought to Bucharest by land, agerpres.ro confirms.
So far, our country has received 1,558,000 doses of vaccine produced by the pharmaceutical company AstraZeneca, and as of 15 February, 591,881 doses have already been used to immunize the population.